
|Articles|January 20, 2022
Daily Medication Pearl: Cyclosporine Ophthalmic Solution (Cequa)
Author(s)Saro Arakelians, PharmD
Cequa ophthalmic solution is indicated to increase tear production in patients with dry eyes.
Advertisement
Medication Pearl of the Day: Cyclosporine ophthalmic solution (Cequa)
Indication: Cequa ophthalmic solution is a calcineurin inhibitor immunosuppressant indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eyes).
Insight:
- Dosing: Instill 1 drop of Cequa twice daily (approximately 12 hours apart) into each eye. Discard the vial immediately after using in both eyes.
- Dosage forms: Ophthalmic solution containing cyclosporine 0.9 mg/mL.
- Adverse events (AEs): The most common AEs reported in greater than 5% of subjects were pain on instillation of drops (22%) and conjunctival hyperemia (6%). Other AEs reported in 1% to 5% of the patients were blepharitis, eye irritation, headache, and urinary tract infection.
- Mechanism of action: Cyclosporine is a calcineurin inhibitor immunosuppressant agent when administered systemically.
- Manufacturer: Sun Pharma
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Recognition and Routine Discussion: Improving Outcomes in Tardive Dyskinesia
2
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
3
Melatonin May Reduce Musculoskeletal Pain and Improve Sleep
4
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
5










































































































